Joe Rogan Talks TruBrain: Record Stress Levels but People Are Just "Given a Pill That Makes Your Environment Tolerable" Instead of Helping People Change

Since the beginning of the pandemic, 41% of adults noted high levels of psychological distress, according to a survey from the Pew Research Center.

New worries about inflation and global instability add to the lingering pandemic concerns, leaving millions of Americans feeling anxious and depressed every day.

But there could be relief. One startup is on a mission to change this. TruBrain and its new wearable technology are helping to relieve anxiety and promote mental calmness. The company creates a line of products focused on stress relief and brain health. From nootropic drinks for brain health and stress relief to wearable brain stimulation technology and other supplements, TruBrain is waging a war on stress.

The venture-backed company has already seen significant traction with over $19 million in lifetime sales and roughly $3.5 million raised from retail investors on StartEngine.

The technology uses vibrations to soothe anxiety. The company received approval from U.S. Food and Drug Administration (FDA) in November to move forward with its wearable device applications. It continues to test and refine the product and is planning a wide market launch.

TruBrain’s breakthrough device is one of several advancements in wearable technology. Fitness trackers like Fitbit monitor heart rates, sleep and activity levels for millions, and companies and researchers are consistently expanding those capabilities with new devices and tech.

To stay updated with top startup news & investments, sign up for Benzinga’s Startup Investing & Equity Crowdfunding Newsletter

For example, in the summer of 2022, researchers at the NYU Tandon School of Engineering built wearable technology that can measure brain mechanics through the skin. It uses electrodermal activity measurement to gauge a person’s mental state, whether they are in pain, panicked or exhausted. The researchers’ goal was to develop a wearable that could alert users to a drop in their mental state and produce stimuli in response, such as calming music or another related action.

Additional advancements in artificial intelligence (AI) and computing power will further enhance wearable health technology. For example, AI can analyze data to alert wearers about an immediate health concern. It can also provide physicians with input about long-term care plans and medical interventions.

Joe Rogan Talks TruBrain

The company continues to offer its lineup of nootropic cognitive-enhancing products. Nootropics, also known as smart drugs or cognitive enhancers are a range of supplements that can benefit the mind. They’re made from natural or synthetic substances and packaged in drinks, pills, bars, powder sticks and other consumed products. TruBrain’s products boost memory and focus so people can stay alert and productive.

TruBrain CEO and Director Chris Thompson previously worked as a brand manager at consumer packaged goods giant Unilever handling billion-dollar brands. Driving much of the company’s innovation is Brian Hill, a UCLA-trained neuroscientist with a focus on studying how attention works within the brain.

See Next: Qnetic Unveils Revolutionary Flywheel Energy Storage System to Accelerate Renewable Energy Adoption

As a guest on Joe Rogan’s popular podcast, Hill discussed the need to change people’s environment to improve their health. He explained to Rogan how depressed people often exhibit asymmetric frontal lobes and how the asymmetry is reversible through scalp stimulation and other means. One of the biggest issues, according to Rogan, is a lack of options for those looking to change. Rather than helping people changes, they’re “given a pill that makes your environment tolerable” but never helping the situation.

In later episodes, Rogan can be seen drinking their nootropic drinks and sharing them with friends noting they “help your memory.”

Capitalizing On Multibillion Dollar Brain Improvement Industry

TruBrain’s wearable device complements its established lineup of drinks, keto bars, powders and other products to boost mental performance and improve sleep. These products are part of the broad nootropics industry, which ResearchandMarkets estimates will become a $6.61 billion industry by 2026. That number represents a 13.7% compound annual growth rate from 2022 to 2026.

TruBrain is using StartEngine to help scale its company, which means anyone can invest for a limited time. The company will use the capital to refine and improve its wearable product offering and advance innovation in nootropics. The company recently moved past $1.2 million funded through StartEngine and has backing from four venture capital funds.

See more on startups investing from Benzinga.